paulclifford
08-09-2013, 09:31 AM
Britain's NHS: A truly humane, government-run, single-payer system of "universal healthcare". Here are some of its strong points:
1. NHS doctors routinely conceal from patients information about innovative new therapies that the NHS doesn’t pay for, so as to not “distress, upset or confuse” them.
http://www.telegraph.co.uk/news/uknews/3322438/Patients-left-in-the-dark-about-life-saving-drugs.html
"There is growing evidence that doctors are concealing treatment options that are not available on the National Health Service but can be obtained privately."
http://news.bbc.co.uk/2/hi/health/7581705.stm
"Doctors are keeping cancer patients in the dark about expensive new drugs that could extend their lives, a poll shows.
A quarter of specialists polled by Myeloma UK said they hid facts about treatments for bone marrow cancer that may be difficult to obtain on the NHS. Doctors said they did not want to "distress, upset or confuse" patients if drugs had not yet been approved by the NHS drugs watchdog NICE."
2. Terminally ill patients are incorrectly classified as “close to death” so as to allow the withdrawal of expensive life support.
http://www.telegraph.co.uk/health/healthnews/6127514/Sentenced-to-death-on-the-NHS.html
"Sentenced to death on the NHS
Patients with terminal illnesses are being made to die prematurely under an NHS scheme to help end their lives, leading doctors have warned.
In a letter to The Daily Telegraph, a group of experts who care for the terminally ill claim that some patients are being wrongly judged as close to death."
3. NHS expert guidelines on the management of high cholesterol are intentionally out of date, putting patients at serious risk, in order to save money.
http://www.dailymail.co.uk/health/article-419083/Sentenced-death-NICE.html
"Sentenced to death by NICE
By DR SARAH JARVIS
Last updated at 22:00 27 November 2006
It's the body that decides which drugs are allowed on the NHS. But in this blistering attack, a leading GP argues the organisation set up to improve care is obsessed by costs, discriminates against the elderly - and ultimately is killing patients:
Recently I was left feeling furious and frustrated after a visit from a patient called Peter. He'd just had a serious heart attack and my job as a GP was to reduce his very high risk of having another.
I knew what the latest research told me was the best way, but I had just basically been forbidden to use it by an official email from the Department of Health.
Instructions about what treatments I can and can't give are issued by a government body called NICE (National Institute for Health and Clinical Excellence).
4. When the government approved an innovative new treatment for elderly blindness, the NHS initially decided to reimburse for the treatment only after patients were already blind in one eye — using the logic that a person blind in one eye can still see, and is therefore not that badly off.
http://news.bbc.co.uk/2/hi/health/7582740.stm
"Lucentis: An NHS dilemma
Outraged campaigners can be found filling newspaper column inches and TV and radio airtime criticising the availability of drugs in one area and not another.
But buried beneath the headlines is a much more complex picture - and nowhere is that more apparent than in the case of the sight-saving drug Lucentis which treats wet age-related macular degeneration, the leading cause of blindness in the UK.
However, the treatment comes at a price - £10,000 for each eye to be precise.
The cost initially prompted the National Institute for Health and Clinical Excellence (NICE), the body which assesses drugs for the NHS, to say it should only be used when someone has gone blind in one eye."
5. While most NHS patients expect to wait five months for a hip operation or knee surgery, leaving them immobile and disabled in the meantime, the actual waiting times are even worse: 11 months for hips and 12 months for knees. (This compares to a wait of 3 to 4 weeks for such procedures in the United States.)
http://news.bbc.co.uk/2/hi/3749801.stm
"NHS waiting time 'underestimated'
People in Britain underestimate the time they would have to wait for an NHS operation, a survey suggests
The poll of 1,000 people, by TNS on behalf of Norwich Union Healthcare, showed most expect to wait five months for a hip operation.
Most wait nearer 11 months, independent medical researchers Dr Fosters said.
Patients also had unrealistic expectations for other operations and many said they did not know where to go to find out waiting times.
Waits 'improving'
For knee surgery, the public were prepared to wait for three months and expected to wait for five months.
The actual wait for a knee replacement is a year, data from Dr Foster suggests.
8 months for cataract surgery
11 months for a hip replacement
12 months for a knee replacement
5 months to repair a slipped disc
5 months for a hernia repair"
6. One in four Britons with cancer is denied treatment with the latest drugs proven to extend life.
http://www.dailymail.co.uk/health/article-2095087/Prostate-cancer-patients-denied-expensive-drug.html
"Now patients are denied 'breakthrough' prostate cancer drug as health watchdogs brand it too expensive
Once-daily pill giving extra months of life is 'too expensive'
Abiraterone is latest cancer drug facing an NHS ban"
Trials show men taking abiraterone and a steroid survived for nearly 15 months, while men given steroid treatment and a ‘dummy’ pill lived for 11 months on average.
But some patients live far longer than expected, including Britons who have survived on the drug for more than four years after developing advanced disease. The drug also eased pain for twice as many men in the trials.
A year’s course of treatment costs £35,000, which Nice says is too expensive.
Campaigners last night condemned the draft decision by Nice. Owen Sharp, chief executive of the Prostate Cancer Charity, which helped fund trials, said: ‘This draft decision is a bitter blow to thousands of men and their families – and must be overturned.’
Patients have been getting abiraterone, also known as Zytiga, through the Cancer Drugs Fund, set up by the Government to pay for treatments not approved by Nice.
But the fund only applies in England until 2014, which denies access to patients in Wales, Scotland and Northern Ireland."
[NB: I love how supporters of the NHS claim that it's an "equitable" system! Tell that to cancer patients denied cutting-edge treatment in Wales, Scotland, and Northern Ireland.]
http://www.dailymail.co.uk/health/article-2300362/Kidney-cancer-patients-denied-life-extending-drug-NHS-watchdog-declares-cost-effective.html
"Kidney cancer patients denied life-extending drug as NHS watchdog declares it 'not cost effective'
NICE says that the NHS should not provide axitinib
The drug can extend the lives of people with advanced kidney cancer but has been deemed not 'cost effective'
It works by cutting off the blood supply to the tumour
Thousands of people with kidney cancer that has spread are to be denied a new pill that could prolong their lives, claim doctors.
Axitinib extends the lives of advanced kidney cancer sufferers by two months on average, according to trials.
But the drug is the latest to face an NHS ban by the rationing watchdog, the National Institute for Health and Clinical Excellence (NICE).
It has already axed another drug that could be used after treatment stops working and the cancer starts growing again."
http://www.theguardian.com/lifeandstyle/2009/oct/21/women-denied-cancer-drug
"Women denied cancer drug that could extend life
The National Institute for Health and Clinical Excellence proposes to reject a breast cancer drug despite its own rule changes on end-of-life treatments
A drug which can give women with advanced breast cancer extra weeks or months of life has been turned down by a government watchdog body for use in the NHS.
The National Institute for Health and Clinical Excellence (Nice) says it proposes to reject Tyverb (lapatinib) in spite of changes in the rules brought in specifically to allow people at the end of their lives to have the chance of new and often expensive treatments.
Tyverb is the only drug licensed for women with advanced breast cancer whose tumours test positive for a protein called HER2 and for whom Herceptin, a Nice-approved drug, is no longer working. In much of the rest of Europe, Tyverb is then given, in combination with a standard chemotherapy drug called capecitabine.
Around 2,000 women in the UK could be eligible for the drug, which has the additional benefit of being taken in pill form, which means that women can stay at home and attempt to live normal lives."
[NB: But the NHS doesn't want to pay for these women to live normal lives. It wants them to die so it can save money.]
http://news.sky.com/story/1073672/cancer-drugs-fund-patients-to-lose-out
Thousands of cancer patients could be denied access to life-extending drugs when a cash pot expires at the end of the year, a charity has warned.
"The £200m-a-year Cancer Drugs Fund allows patients in England to access drugs approved by their doctors but which have not been cleared for widespread use on the NHS.
It was designed to make it easier for doctors to prescribe treatments even if they have not yet been approved by the National Institute for Health and Care Excellence (Nice).
The scheme is due to run until 2014, but charity Beating Bowel Cancer says the drugs may no longer be made available when the public funding runs out."
http://www.telegraph.co.uk/health/healthnews/8349297/Cancer-sufferers-refused-life-extending-drugs-despite-Government-pledge.html
"Cancer Sufferers Refused Life-Extending Drugs Despite Government Pledge"
7. Those who seek to pay for such drugs on their own are expelled from the NHS system, for making the government look bad, and are forced to pay for the entirety of their own care for the rest of their lives.
http://www.nationalreview.com/agenda/244934/non-demagogic-disquisition-death-panels-avik-roy
"When the British National Health Service was founded on July 5, 1948, expectations were sky-high. The NHS, in the words of one official, would be the “envy of the world.” 62 years later, by all objective measures, the NHS is the worst health-care system in the developed world. Costs have exploded. The NHS uses the most aggressive price controls and rationing procedures in the West, going so far as to assign a price to the “quality-adjusted life year” that is required to extend it. And yet, from 1996 to 2008, national health care expenditures in the U.K. have grown at 6.7% a year, compared to 5.5% in the U.S. over the same period.
These comments were not made solely with end-of-life care in mind. But they were made with the NHS in mind: a system in which treatments that don’t extend life by £20,000-30,000 per quality-adjusted life year are not paid for by the government. And if you choose to buy that forbidden treatment on your own, you are kicked off the NHS for life.
Those who are in their last years of lives are expected to do their part for the national budget, which is to die inexpensively.
The Quality-Adjusted Life Year (QALY) methodology that the British use is precisely oriented at reducing care for the elderly, and steering it to younger patients, for whom effective therapies will lead to a longer, fuller life. For those in their 80s, in Britain, the NHS offers little. Recent studies have shown that Britons have the worst survival rates in the developed world after being diagnosed with a disease, like cancer, or a chronic condition, like heart disease. Britain may have the best tennis courts in the world, but it has a broken health care system. When you’re young and healthy, it’s great. You go to do the doctor (if you can get an appointment), and you don’t have to think of any financial considerations. But if you’re old and unhealthy, watch out.
It comes down to this: if the government is funding health care, and simultaneously funding end-of-life counseling, the government has a conflict of interest. The government has a financial incentive to encourage people to “pull the plug on granny,” regardless of whether or not that is consistent with granny’s, or her family’s, wishes. It is, at bottom, the same reason we insist on a free, independent press (and free speech in general): when the government controls the media, it has a conflict of interest; i.e., an incentive to promote journalism that is favorable to the government."
8. Britons diagnosed with cancer or heart attacks are more likely to die, and more quickly, than those of most other developed nations. Britain’s survival rates for these diseases are “little better than [those] of former Communist countries.”
http://www.dailymail.co.uk/news/article-1234276/Britain-sick-man-Europe-Heart-cancer-survival-rates-worst-developed-world.html
"Britain, the sick man of Europe:
Heart and cancer survival rates among worst in developed world
"British health care is little better than that of former Communist countries, which spend a fraction of the billions poured into the NHS.
A survey published yesterday by the Organisation for Economic Cooperation and Development sees Britain languishing with the Czech Republic and Poland in international league tables on health."
* * * * * * * * * * * * * * * *
The Quality Adjusted Life Year (QALY). A wonderful idea!
If you're young and you get sick, the British government will pay your bills, but you'll wait months or years for treatment.
If you're old and you get sick, the British government will have a financial conflict-of-interest in spending taxpayer money to keep you alive beyond your useful taxpaying years. The NHS wants you to die in order to free up beds and save tax revenues on treatments for younger people. And if your family tries to purchase private treatment off the NHS system, you're kicked off of it forever.
And whether you're young or old, rich or poor, the NHS will deny you the best care with the latest drugs and therapies because their version of a "death panel" — the NICE — will decide that these cutting-edge cures are not cost-effective.
The main advantage to the NHS (and other universal, single-payer healthcare systems similar to it) is bragging rights: "Our government gives us free healthcare! What! You mean, yours doesn't? How inhumane!"
Yes, the NHS is a truly humane healthcare system — as long as you don't get sick.
1. NHS doctors routinely conceal from patients information about innovative new therapies that the NHS doesn’t pay for, so as to not “distress, upset or confuse” them.
http://www.telegraph.co.uk/news/uknews/3322438/Patients-left-in-the-dark-about-life-saving-drugs.html
"There is growing evidence that doctors are concealing treatment options that are not available on the National Health Service but can be obtained privately."
http://news.bbc.co.uk/2/hi/health/7581705.stm
"Doctors are keeping cancer patients in the dark about expensive new drugs that could extend their lives, a poll shows.
A quarter of specialists polled by Myeloma UK said they hid facts about treatments for bone marrow cancer that may be difficult to obtain on the NHS. Doctors said they did not want to "distress, upset or confuse" patients if drugs had not yet been approved by the NHS drugs watchdog NICE."
2. Terminally ill patients are incorrectly classified as “close to death” so as to allow the withdrawal of expensive life support.
http://www.telegraph.co.uk/health/healthnews/6127514/Sentenced-to-death-on-the-NHS.html
"Sentenced to death on the NHS
Patients with terminal illnesses are being made to die prematurely under an NHS scheme to help end their lives, leading doctors have warned.
In a letter to The Daily Telegraph, a group of experts who care for the terminally ill claim that some patients are being wrongly judged as close to death."
3. NHS expert guidelines on the management of high cholesterol are intentionally out of date, putting patients at serious risk, in order to save money.
http://www.dailymail.co.uk/health/article-419083/Sentenced-death-NICE.html
"Sentenced to death by NICE
By DR SARAH JARVIS
Last updated at 22:00 27 November 2006
It's the body that decides which drugs are allowed on the NHS. But in this blistering attack, a leading GP argues the organisation set up to improve care is obsessed by costs, discriminates against the elderly - and ultimately is killing patients:
Recently I was left feeling furious and frustrated after a visit from a patient called Peter. He'd just had a serious heart attack and my job as a GP was to reduce his very high risk of having another.
I knew what the latest research told me was the best way, but I had just basically been forbidden to use it by an official email from the Department of Health.
Instructions about what treatments I can and can't give are issued by a government body called NICE (National Institute for Health and Clinical Excellence).
4. When the government approved an innovative new treatment for elderly blindness, the NHS initially decided to reimburse for the treatment only after patients were already blind in one eye — using the logic that a person blind in one eye can still see, and is therefore not that badly off.
http://news.bbc.co.uk/2/hi/health/7582740.stm
"Lucentis: An NHS dilemma
Outraged campaigners can be found filling newspaper column inches and TV and radio airtime criticising the availability of drugs in one area and not another.
But buried beneath the headlines is a much more complex picture - and nowhere is that more apparent than in the case of the sight-saving drug Lucentis which treats wet age-related macular degeneration, the leading cause of blindness in the UK.
However, the treatment comes at a price - £10,000 for each eye to be precise.
The cost initially prompted the National Institute for Health and Clinical Excellence (NICE), the body which assesses drugs for the NHS, to say it should only be used when someone has gone blind in one eye."
5. While most NHS patients expect to wait five months for a hip operation or knee surgery, leaving them immobile and disabled in the meantime, the actual waiting times are even worse: 11 months for hips and 12 months for knees. (This compares to a wait of 3 to 4 weeks for such procedures in the United States.)
http://news.bbc.co.uk/2/hi/3749801.stm
"NHS waiting time 'underestimated'
People in Britain underestimate the time they would have to wait for an NHS operation, a survey suggests
The poll of 1,000 people, by TNS on behalf of Norwich Union Healthcare, showed most expect to wait five months for a hip operation.
Most wait nearer 11 months, independent medical researchers Dr Fosters said.
Patients also had unrealistic expectations for other operations and many said they did not know where to go to find out waiting times.
Waits 'improving'
For knee surgery, the public were prepared to wait for three months and expected to wait for five months.
The actual wait for a knee replacement is a year, data from Dr Foster suggests.
8 months for cataract surgery
11 months for a hip replacement
12 months for a knee replacement
5 months to repair a slipped disc
5 months for a hernia repair"
6. One in four Britons with cancer is denied treatment with the latest drugs proven to extend life.
http://www.dailymail.co.uk/health/article-2095087/Prostate-cancer-patients-denied-expensive-drug.html
"Now patients are denied 'breakthrough' prostate cancer drug as health watchdogs brand it too expensive
Once-daily pill giving extra months of life is 'too expensive'
Abiraterone is latest cancer drug facing an NHS ban"
Trials show men taking abiraterone and a steroid survived for nearly 15 months, while men given steroid treatment and a ‘dummy’ pill lived for 11 months on average.
But some patients live far longer than expected, including Britons who have survived on the drug for more than four years after developing advanced disease. The drug also eased pain for twice as many men in the trials.
A year’s course of treatment costs £35,000, which Nice says is too expensive.
Campaigners last night condemned the draft decision by Nice. Owen Sharp, chief executive of the Prostate Cancer Charity, which helped fund trials, said: ‘This draft decision is a bitter blow to thousands of men and their families – and must be overturned.’
Patients have been getting abiraterone, also known as Zytiga, through the Cancer Drugs Fund, set up by the Government to pay for treatments not approved by Nice.
But the fund only applies in England until 2014, which denies access to patients in Wales, Scotland and Northern Ireland."
[NB: I love how supporters of the NHS claim that it's an "equitable" system! Tell that to cancer patients denied cutting-edge treatment in Wales, Scotland, and Northern Ireland.]
http://www.dailymail.co.uk/health/article-2300362/Kidney-cancer-patients-denied-life-extending-drug-NHS-watchdog-declares-cost-effective.html
"Kidney cancer patients denied life-extending drug as NHS watchdog declares it 'not cost effective'
NICE says that the NHS should not provide axitinib
The drug can extend the lives of people with advanced kidney cancer but has been deemed not 'cost effective'
It works by cutting off the blood supply to the tumour
Thousands of people with kidney cancer that has spread are to be denied a new pill that could prolong their lives, claim doctors.
Axitinib extends the lives of advanced kidney cancer sufferers by two months on average, according to trials.
But the drug is the latest to face an NHS ban by the rationing watchdog, the National Institute for Health and Clinical Excellence (NICE).
It has already axed another drug that could be used after treatment stops working and the cancer starts growing again."
http://www.theguardian.com/lifeandstyle/2009/oct/21/women-denied-cancer-drug
"Women denied cancer drug that could extend life
The National Institute for Health and Clinical Excellence proposes to reject a breast cancer drug despite its own rule changes on end-of-life treatments
A drug which can give women with advanced breast cancer extra weeks or months of life has been turned down by a government watchdog body for use in the NHS.
The National Institute for Health and Clinical Excellence (Nice) says it proposes to reject Tyverb (lapatinib) in spite of changes in the rules brought in specifically to allow people at the end of their lives to have the chance of new and often expensive treatments.
Tyverb is the only drug licensed for women with advanced breast cancer whose tumours test positive for a protein called HER2 and for whom Herceptin, a Nice-approved drug, is no longer working. In much of the rest of Europe, Tyverb is then given, in combination with a standard chemotherapy drug called capecitabine.
Around 2,000 women in the UK could be eligible for the drug, which has the additional benefit of being taken in pill form, which means that women can stay at home and attempt to live normal lives."
[NB: But the NHS doesn't want to pay for these women to live normal lives. It wants them to die so it can save money.]
http://news.sky.com/story/1073672/cancer-drugs-fund-patients-to-lose-out
Thousands of cancer patients could be denied access to life-extending drugs when a cash pot expires at the end of the year, a charity has warned.
"The £200m-a-year Cancer Drugs Fund allows patients in England to access drugs approved by their doctors but which have not been cleared for widespread use on the NHS.
It was designed to make it easier for doctors to prescribe treatments even if they have not yet been approved by the National Institute for Health and Care Excellence (Nice).
The scheme is due to run until 2014, but charity Beating Bowel Cancer says the drugs may no longer be made available when the public funding runs out."
http://www.telegraph.co.uk/health/healthnews/8349297/Cancer-sufferers-refused-life-extending-drugs-despite-Government-pledge.html
"Cancer Sufferers Refused Life-Extending Drugs Despite Government Pledge"
7. Those who seek to pay for such drugs on their own are expelled from the NHS system, for making the government look bad, and are forced to pay for the entirety of their own care for the rest of their lives.
http://www.nationalreview.com/agenda/244934/non-demagogic-disquisition-death-panels-avik-roy
"When the British National Health Service was founded on July 5, 1948, expectations were sky-high. The NHS, in the words of one official, would be the “envy of the world.” 62 years later, by all objective measures, the NHS is the worst health-care system in the developed world. Costs have exploded. The NHS uses the most aggressive price controls and rationing procedures in the West, going so far as to assign a price to the “quality-adjusted life year” that is required to extend it. And yet, from 1996 to 2008, national health care expenditures in the U.K. have grown at 6.7% a year, compared to 5.5% in the U.S. over the same period.
These comments were not made solely with end-of-life care in mind. But they were made with the NHS in mind: a system in which treatments that don’t extend life by £20,000-30,000 per quality-adjusted life year are not paid for by the government. And if you choose to buy that forbidden treatment on your own, you are kicked off the NHS for life.
Those who are in their last years of lives are expected to do their part for the national budget, which is to die inexpensively.
The Quality-Adjusted Life Year (QALY) methodology that the British use is precisely oriented at reducing care for the elderly, and steering it to younger patients, for whom effective therapies will lead to a longer, fuller life. For those in their 80s, in Britain, the NHS offers little. Recent studies have shown that Britons have the worst survival rates in the developed world after being diagnosed with a disease, like cancer, or a chronic condition, like heart disease. Britain may have the best tennis courts in the world, but it has a broken health care system. When you’re young and healthy, it’s great. You go to do the doctor (if you can get an appointment), and you don’t have to think of any financial considerations. But if you’re old and unhealthy, watch out.
It comes down to this: if the government is funding health care, and simultaneously funding end-of-life counseling, the government has a conflict of interest. The government has a financial incentive to encourage people to “pull the plug on granny,” regardless of whether or not that is consistent with granny’s, or her family’s, wishes. It is, at bottom, the same reason we insist on a free, independent press (and free speech in general): when the government controls the media, it has a conflict of interest; i.e., an incentive to promote journalism that is favorable to the government."
8. Britons diagnosed with cancer or heart attacks are more likely to die, and more quickly, than those of most other developed nations. Britain’s survival rates for these diseases are “little better than [those] of former Communist countries.”
http://www.dailymail.co.uk/news/article-1234276/Britain-sick-man-Europe-Heart-cancer-survival-rates-worst-developed-world.html
"Britain, the sick man of Europe:
Heart and cancer survival rates among worst in developed world
"British health care is little better than that of former Communist countries, which spend a fraction of the billions poured into the NHS.
A survey published yesterday by the Organisation for Economic Cooperation and Development sees Britain languishing with the Czech Republic and Poland in international league tables on health."
* * * * * * * * * * * * * * * *
The Quality Adjusted Life Year (QALY). A wonderful idea!
If you're young and you get sick, the British government will pay your bills, but you'll wait months or years for treatment.
If you're old and you get sick, the British government will have a financial conflict-of-interest in spending taxpayer money to keep you alive beyond your useful taxpaying years. The NHS wants you to die in order to free up beds and save tax revenues on treatments for younger people. And if your family tries to purchase private treatment off the NHS system, you're kicked off of it forever.
And whether you're young or old, rich or poor, the NHS will deny you the best care with the latest drugs and therapies because their version of a "death panel" — the NICE — will decide that these cutting-edge cures are not cost-effective.
The main advantage to the NHS (and other universal, single-payer healthcare systems similar to it) is bragging rights: "Our government gives us free healthcare! What! You mean, yours doesn't? How inhumane!"
Yes, the NHS is a truly humane healthcare system — as long as you don't get sick.